Ultrasound
Best initial study for a superficial palpable lesion; evaluates solid versus cystic architecture, vascularity, multiplicity, and cervical nodes and facilitates FNA/core biopsy. [pmc.ncbi.nlm.nih][epos.myesr]
Parotid tumors
Most parotid tumors are benign, with pleomorphic adenoma and Warthin tumor accounting for the majority. Imaging narrows the differential and defines surgical extent, but substantial overlap—especially between benign tumors and low-grade malignancies—means that cytologic or histologic confirmation is commonly required. [epos.myesr][pmc.ncbi.nlm.nih]
Imaging approach
MRI with contrast
Preferred for deep-lobe lesions, tissue characterization, extraglandular extension, skull-base involvement, perineural spread, and nodal disease. [pmc.ncbi.nlm.nih][link.springer]
CT with contrast
Useful for acute presentations, calcification, bone involvement, deep extension, nodal disease, and patients unable to undergo MRI. [pmc.ncbi.nlm.nih]
Common benign tumors
| Tumor | Typical radiologic findings |
|---|---|
| Pleomorphic adenoma | Well-defined, smooth or lobulated mass; markedly T2 hyperintense due to myxoid/chondroid matrix; high ADC; progressive or delayed enhancement. Larger lesions become heterogeneous with hemorrhage, necrosis, or calcification and may have a low-T2 capsule. [pmc.ncbi.nlm.nih][epos.myesr][pmc.ncbi.nlm.nih] |
| Warthin tumor | Usually well-circumscribed and located in the parotid tail; often multifocal or bilateral; heterogeneous solid-cystic appearance. Proteinaceous or hemorrhagic cysts may be T1 hyperintense; solid components are commonly low/intermediate T2, restrict diffusion, and show early enhancement with washout. [pmc.ncbi.nlm.nih][epos.myesr][pmc.ncbi.nlm.nih] |
| Oncocytoma | Well-defined solid mass with avid, often homogeneous enhancement; T1 hypointense and T2 iso-/hypointense. It may demonstrate a central scar and a “vanishing” appearance on fat-suppressed T2 and postcontrast images; ADC is usually higher than in Warthin tumor. [epos.myesr][pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih][link.springer] |
| Basal cell adenoma | Small, round or oval, well-circumscribed superficial-lobe mass; low T1 and variable low-to-mildly-high T2 signal; rapid, often persistent enhancement. Cystic or hemorrhagic components are relatively common. [epos.myesr][pmc.ncbi.nlm.nih] |
| Schwannoma | Fusiform or circumscribed enhancing mass along the intraparotid facial nerve; usually T2 hyperintense. Facial-nerve canal enhancement or enlargement and denervation changes may help establish neural origin. |
Malignant tumors
| Tumor | Typical radiologic findings |
|---|---|
| Mucoepidermoid carcinoma | Low-grade lesions may be well circumscribed and resemble benign tumors, often with T2-bright mucinous cysts. High-grade lesions are predominantly solid, heterogeneous, lower on T2, infiltrative, and may demonstrate necrosis and nodal metastases. [link.springer][epos.myesr][pmc.ncbi.nlm.nih] |
| Adenoid cystic carcinoma | Enhancing infiltrative mass with a marked tendency for perineural spread. Evaluate the facial nerve, auriculotemporal nerve/V3, stylomastoid foramen, facial canal, foramen ovale, and skull base. [link.springer][link.springer][epos.myesr] |
| Acinic cell carcinoma | Often a well-circumscribed, slowly growing parotid-tail mass that can closely mimic a benign lesion; may be multifocal or bilateral. Imaging findings are nonspecific, particularly in low-grade tumors. [link.springer][epos.myesr] |
| Salivary duct carcinoma | Usually an aggressive, irregular, infiltrative solid mass with heterogeneous enhancement, necrosis, perineural spread, and regional adenopathy. |
| Carcinoma ex pleomorphic adenoma | Suspect when a longstanding mass develops rapid growth, pain, or facial weakness; imaging may show an infiltrative component, necrosis, hemorrhage, low T2 signal, nodal disease, or extension beyond a preexisting circumscribed mass. |
| Lymphoma | Homogeneous solid mass or multiple bilateral parotid nodules, often with associated cervical adenopathy; typically demonstrates pronounced diffusion restriction and low ADC. [pmc.ncbi.nlm.nih][inis.iaea] |
| Intraparotid nodal metastases | Single or multiple parotid-tail/pretragal masses, sometimes necrotic, with or without cervical adenopathy. Consider cutaneous squamous cell carcinoma or melanoma of the scalp, face, ear, or external auditory canal; imaging may be indistinguishable from a primary parotid tumor. [epos.myesr][pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih] |
Malignant imaging signs
The most reliable warning features are ill-defined or infiltrative margins, extraglandular extension, perineural spread, adjacent tissue or bone invasion, and pathologic lymph nodes. Low T2 signal, diffusion restriction, necrosis, rapid growth, pain, and facial-nerve dysfunction add concern but are not independently specific. [link.springer][pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih]
Conversely, smooth margins and homogeneous architecture favor benignity but do not exclude a low-grade malignancy. Cystic change is also nonspecific because it occurs in Warthin tumor, pleomorphic adenoma, basal cell adenoma, and low-grade mucoepidermoid carcinoma. [pmc.ncbi.nlm.nih][epos.myesr]
Pattern recognition
- Very T2 bright + high ADC + progressive enhancement: Pleomorphic adenoma. [pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih]
- Parotid tail + solid-cystic + low ADC + early washout: Warthin tumor. [pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih]
- Low T2 + avid homogeneous enhancement + higher ADC than Warthin: Oncocytoma. [epos.myesr][link.springer]
- Marked diffusion restriction + multiple nodules/nodes: Lymphoma.
- Cystic lesion with enhancing solid components: Warthin tumor or low-grade mucoepidermoid carcinoma. [link.springer][epos.myesr]
- Infiltrative mass + perineural spread: Adenoid cystic carcinoma or another high-grade malignancy. [epos.myesr][link.springer]
- Parotid-tail nodules in a patient with facial/scalp skin cancer: Intraparotid nodal metastases. [pmc.ncbi.nlm.nih][pmc.ncbi.nlm.nih]
Reporting checklist
Report the tumor’s superficial- versus deep-lobe location, size, margins, solid/cystic composition, T1/T2 signal, enhancement, diffusion characteristics, multiplicity, and relationship to the retromandibular vein. Also assess the facial and trigeminal nerve pathways, parapharyngeal space, mandible/skull base, skin and masticator space, intraparotid nodes, and cervical nodal levels. [link.springer][pmc.ncbi.nlm.nih]
Source limitations
The supplied text includes abbreviated citation markers (epos.myesr, pmc.ncbi.nlm.nih, link.springer, and inis.iaea), without article titles or URLs. These markers are retained as supplied; specific references cannot be identified from them. No diagnostic images were supplied.